Sree Rayalaseema Hi-Strength Hypo Limited announced its unaudited standalone and consolidated financial results for the third quarter and nine-month period ended December 31, 2025. The company reported a consolidated revenue from operations of ₹141.17 Crore for Q3 FY26, representing a 1.95% increase compared to ₹138.47 Crore in the corresponding quarter of the previous year. The net profit for the quarter stood at ₹24.35 Crore, showing a 3.48% growth over the ₹23.53 Crore reported in the same period last year. On a quarter-on-quarter (QoQ) basis, revenue decreased by 25.50% from ₹189.49 Crore in Q2 FY26, while net profit increased by 4.55% from ₹23.29 Crore.

Sree Rayalaseema Hi-Strength Hypo Limited is a leading Indian chemical manufacturer and a significant global player in the production of Calcium Hypochlorite using state-of-the-art sodium process technology. Based in Andhra Pradesh, the company’s diverse product portfolio includes stable bleaching powder, sulphuric acid, chloramine, and water treatment chemicals. Beyond chemicals, it operates in power generation through wind, solar, and thermal energy. In recent 2025 updates, the company successfully held its 20th Annual General Meeting in September and has maintained a consistent dividend-paying track record, declaring a dividend of ₹3 per share in May 2025. The company remains nearly debt-free and continues to export its specialized products to over 40 countries, reinforcing its status as a recognized export house. Prominent institutional and corporate stakeholders include Gowri Gopal Hospitals Private Limited and TGV Projects and Investments Private Limited, while the Investor Education and Protection Fund (IEPF) holds a notable 6.75% stake as of December 2025.